Cardiac function study in hard metal workers

https://doi.org/10.1016/0048-9697(94)90148-1Get rights and content

Abstract

The induction of cardiac effects in hard metal workers is uncertain. This study investigates cardiac function of a group of 31 hard metal workers with or without pulmonary disease. The average duration of exposure to cobalt containing dusts was 10.4 years (range 1–30), while the environmental levels of cobalt exposure ranged from 0.09 to 13.6 mg/m3 Co. Cardiac function has been studied by: EGG (electrocardiogram), exercise test (ET), ECG 24 h according to Holter (ECGH), echocardiogram (ECHO) and radionuclide angiocardiography with 99Tc (RNA). The aims of this work were (i) to show the existence of cobalt myocardiopathy in the workers analyzed and, (ii) to find an early indicator of cardiac dysfunction which could be used in the clinical examination of hard metal workers. Within the group of patients with hard metal lung disease, cases of myocardiopathy of doubtful aetiology have been found. The cardiac indexes obtained through RNA show ventricular dysfunction in healthy hard metal workers which could be a manifestation of initial pulmonary artery hypertension or of an early occult cor pulmonale due to an unknown fibrotic lung disease.

References (35)

  • J. Sullivan et al.

    Tissue cobalt content in “beer drinkers' myocardiopathy”

    J. Lab. Clin. Med.

    (1968)
  • A. La Grutta et al.

    Intossicazione cronica da cobalto. Presentazione di un caso clinico di cardiomiopatia

    Minerva Pediatrica

    (1984)
  • C. Bianchi et al.

    Cobalt-induced hypothyroidism, cardiomyopathy, polycithemia and hypertricosis; a case report

    J. Trace Elem. Exp. Med.

    (1989)
  • G. Rona

    Experimental aspects of cobalt cardiomyopathy

    Br. Heart J.

    (1971)
  • G.S. Wiberg et al.

    Effect of cobalt ions on myocardial metabolism

    Can. J. Biochem.

    (1967)
  • D.V. Unverferth et al.

    The evolution of B-adrenergic dysfunction during the induction of canine cobalt cardiomyopathy

    Cardiovasc. Res.

    (1984)
  • M. Barborik et al.

    Cardiomyopathy accompanying industrial cobalt exposure

    Br. Heart J.

    (1972)
  • Cited by (13)

    • Metals and risk of incident metabolic syndrome in a prospective cohort of midlife women in the United States

      2022, Environmental Research
      Citation Excerpt :

      The cardiovascular effects of cobalt, in contrast, have been more extensively examined in occupational settings. Epidemiologic studies in highly occupationally exposed populations have found associations of cobalt exposure with cardiovascular endpoints, including altered diastole, reduced left ventricular systolic function, left ventricular and atrial hypertrophy, reversible electrocardiographic changes, arrhythmias, and hypertension (D'Adda et al., 1994; Horowitz et al., 1988; Leyssens et al., 2017; Linna et al., 2004; Machado et al., 2012; Oldenburg et al., 2009). Cobalt appears to exert toxic effects through the inhibition of cellular respiration due to interruption of the mitochondrial function (Leyssens et al., 2017).

    • Effects of CoCr metal wear debris generated from metal-on-metal hip implants and Co ions on human monocyte-like U937 cells

      2015, Toxicology in Vitro
      Citation Excerpt :

      Co corrodes faster than Cr under physiological conditions (Xia et al., 2011) and, in contrast to Cr, Co ions tend to remain mobile, which is reflected in the higher levels measured in blood, allowing the ions to reach and enter remote organs (Afolaranmi et al., 2012). Elevated Co concentrations in patients with MoM implants are a concern, since increased Co levels in blood have also been reported to be associated with neurological (hand tremor, incoordination, cognitive decline, depression, vertigo, hearing loss, and visual changes) (Oldenburg et al., 2009; Tower, 2010), cardiac (myocardiopathy) (Dadda et al., 1994; Seghizzi et al., 1994; Gilbert et al., 2013) and endocrine (aberrant oestrogen signalling, altered the production or circulation of sex hormones, and altered thyroid metabolism) (Keegan et al., 2007; Oldenburg et al., 2009) symptoms. In addition to the above, data from the seventh annual report of the National Joint Registry for England and Wales showed high failure rates for MoM hip prostheses (http://www.njrcentre.org.uk/njrcentre/portals/0/njr%207th%20annual%20report%202010.pdf), which led to the market recall of the DePuy ASRTM, both the Resurfacing and XL Systems in August 2010 (DePuy International Ltd., Leeds, UK) (MDA/2010/069).

    View all citing articles on Scopus
    View full text